Manchester first to implement Congenica’s Sapientia technology to provide fast, accurate diagnosis for genetic diseases
10,000 new patients a year are treated by the Manchester Centre for Genomic Medicine (MCGM) for a range of rare diseases including cancers, developmental disorders and disabilities including hearing and vision loss - diagnosis can be time-consuming and invasive.